TABLE 2.
Subject
|
|||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Across muscle | |||||
FDI-FPI | 10 | 15 | 11 | 26 | 12 |
FPL-FDI | 14 | 14 | 12 | 16 | 11 |
FPL-FPI | 10 | 10 | 10 | 15 | 12 |
Within muscle | |||||
FDI-FDI | 2 | 3 | 1 | 5 | 0 |
FPI-FPI | 1 | 1 | 0 | 7 | 1 |
Subject
|
|||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Across muscle | |||||
FDI-FPI | 10 | 15 | 11 | 26 | 12 |
FPL-FDI | 14 | 14 | 12 | 16 | 11 |
FPL-FPI | 10 | 10 | 10 | 15 | 12 |
Within muscle | |||||
FDI-FDI | 2 | 3 | 1 | 5 | 0 |
FPI-FPI | 1 | 1 | 0 | 7 | 1 |